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Abstract
Background: Collaboration between Sub-Saharan African researchers is important for the generation and transfer
of health technology assessment (HTA) evidence, in order to support priority-setting in health. The objective of this
analysis was to evaluate collaboration patterns between countries.
Methods: We conducted a rapid evidence assessment that included a random sample of health economic
evaluations carried out in 20 countries (Angola, Botswana, Congo, Lesotho, Madagascar, Malawi, Mauritius,
Mozambique, Namibia, Seychelles, South Africa, Swaziland, Tanzania, Zambia, Zimbabwe, Ghana, Kenya, Nigeria,
Ethiopia, Uganda). We conducted bibliometric network analysis based on all first authors with a Sub-Saharan
African academic affiliation and their co-authored publications (“network-articles”). Then we produced a connection
map of collaboration patterns among Sub-Saharan African researchers, reflecting the number of network-articles
and the country of affiliation of the main co-authors.
Results: The sample of 119 economic evaluations mostly related to treatments of communicable diseases, in
particular HIV/AIDS (42/119, 35.29 %) and malaria (26/119, 21.85 %). The 39 first authors from Sub-Saharan African
institutions together co-authored 729 network-articles. The network analysis showed weak collaboration between
health economic researchers in Sub-Saharan Africa, with researchers being more likely to collaborate with Europe
and North America than with other African countries. South Africa stood out as producing the highest number of
health economic evaluations and collaborations.
Conclusions: The development and evaluation of HTA research networks in Sub-Saharan Africa should be supported,
with South Africa central to any such efforts. Organizations and institutions from high income countries interested
in supporting priority setting in Sub-Saharan Africa should include promoting collaboration as part of their agendas,
in order to take advantage of the potential transferability of results and methods of the available health economic
analyses in Africa and internationally.
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Background
Allocation of scarce health care resources is a key chal-
lenge facing the health sector globally. Low and middle in-
come countries (LMIC) in particular are experiencing a
considerable increase in health expenditures per-capita
[1]. For instance, in Thailand, Ghana and Ethiopia, health
expenditures per-capita grew more than 195 % between
2003 and 2013. At the same time, many of these same
countries are undertaking major reforms in pursuit of
Universal Health Coverage [2]. As a result there is a need
for health resource allocation strategies that are effective,
efficient and equitable. As the historic analysis by Rebelo
[3] shows, health economics has been fundamental in
helping to break down the complexity of optimal health
resource allocation, and health technology assessment
(HTA) has been identified as one such tool to support
priority setting processes [4, 5].
In the case of Sub-Saharan Africa, the number of stud-
ies that use HTA tools such as cost-effectiveness analysis
to inform health priority setting has been increasing. Ac-
cording to the Centre for Reviews and Dissemination
(CDR) database [6], more than 50 % of the articles pub-
lished after 1994 relating to HTA analysis in Sub-Saharan
Africa (literature reviews, economic evaluations and other
applications of HTA tools) were published between 2008
and 2013. An analysis conducted by the Office of Health
Economics (OHE) and NICE International that explored
the demand for and supply of evidence-informed priority-
setting in a selected group of LMIC suggests that human
technical capacity remains a limiting factor to fulfilling the
demand for health economic evidence to support the
decision-making process [2, 7]. This capacity varies be-
tween countries in the Sub-Saharan African region, and
progress is reflected for instance in the number of cost-
effectiveness analyses registered in the NHS Economic
Evaluation Database (NHS EED) whose authors are affili-
ated to South Africa [6]. This variation in capacity has also
been documented in related fields such as biomedical and
health research publications [8, 9]. This is reflected in the
analysis by Wagstaff and Culyer [10], which pointed out
large differences among African countries in terms of the
number of health economic articles produced. Such varia-
tions suggest that Sub-Saharan Africa countries with less
capacity might benefit from adopting, adapting and con-
textualising transferrable evidence generated by neigh-
bouring countries in the region, and be more able to set
their own evidence-informed priorities in health despite
being less capable of producing their own economic and
clinical evaluations of health interventions.
One question is whether the evidence collected and the
decisions adopted in one context are applicable to an-
other. In this regard, the Sub-Saharan African countries
share similarities not only in terms of epidemiological pro-
files, but also in terms of the macro-level decision making
processes and related macro-level contextual factors that
affect decision making. Macro-level decision-making pro-
cesses are defined as those concerning the organisation
and the architecture of a health care system; for example,
those related to service delivery arrangements, the organ-
isation of the health workforce, health information sys-
tems and disease priority setting [11]. A qualitative study
conducted by Jenniskens, Tiendrebeogo [12], in which
stakeholders from five African countries were interviewed,
reflects their similarities in terms of contextual factors,
health priorities, accessibility to services and quality of
health care. Given the similarities in epidemiological pro-
file and contextual factors, it is expected that the
countries with less capacity would benefit from using
the available evidence as well as the decisions made
in other Sub-Saharan African countries.
Replicating HTA that has already been conducted else-
where would be worthwhile only if the expected value of
improved decision making (based on more accurate,
contextualized evidence) outweighed the costs of repeat-
ing the exercise specifically for local conditions. Instead,
coordinating efforts to collect and share knowledge could
enhance the local decision making process, allowing the
results of HTA evidence to be adopted or adapted in a
way that more accurately reflects local contexts without a
prohibitive increase in costs. In this regard, the similarities
as well as differences in capacity between the Sub-Saharan
African countries open the door to possible mutually sup-
porting streams of HTA-based activities with potential for
cross-transferability. Even more important, the capacity
gaps linked to the generation and interpretation of eco-
nomic and clinical evidence for HTA could be partially
overcome by the transfer of information between those
African countries with social and economic similarities.
In addition, the findings of Kularatna, Whitty [13] sug-
gest that health state valuations (e.g. EQ-5D and health
state preference studies) from LMICs are scarce; of the
17 health state valuations in LMICs only two were from
Africa [13]. Furthermore, the quality of the evidence is
also a concern, and a systematic review of economic
evaluations in Ghana suggested that a more coordinated
African approach to the assessment of new health treat-
ments could potentially improve the quality of the evidence
for the region [14]. A successful example of a coordinated
regional approach is HTAsialink. This is a collaborative
networking organization consisting of 15 institutions that
includes Asia’s HTA agencies, representatives of Asian
Ministries of Health and two organizations outside Asia:
the Australian Safety and Efficacy Register of New Inter-
ventional Procedures - Surgical (ASERNIP-S) and the UK’s
National Insitute for Health and Care Excellence (NICE).
Currently, HTAsialink members are collaborating in a re-
search project to define the social value of the QALY
through the analysis of household surveys across Asia [15].
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Furthermore, HTAsialink produces an electronic newslet-
ter which is distributed to the members to share informa-
tion and strength the collaboration between the members
[16].
In this context, it would be useful to examine collabo-
rations between Sub-Saharan African health economic
researchers. There is currently little evidence of the spe-
cific effects of collaboration on the transferability of
HTA evidence and on the improvement of the countries’
capacities to develop HTA programs. Nevertheless, the
effect of collaboration on research outputs has been in-
vestigated in different areas of health research. For in-
stance, Lachat, Roberfroid [17] examined the network of
African researchers collaborating on the topic of nutri-
tion, and the results suggest that this has not achieved
its full potential. Similarly, collaboration patterns of the
cardiovascular disease research in Africa suggest that
limited resources to support research in Africa could
be enhanced by leveraging closer partnership between
African researchers [18]. The literature also suggests
that collaboration improves transferability of information
in different fields of research. This has been shown for
genetics, drug development and nanotechnology [19–23].
Collaborations between researchers trigger spillovers
in the form of expansion of ideas and advancement of
research, and it would be reasonable to assume that
the same could apply to HTA research.
The study of co-authored publications is a standard
way of measuring research collaborations [17, 24–26].
The present analysis explores the relationships between
Sub-Saharan African health economic researchers and
their respective co-authors. Collaboration patterns
between countries might indicate the extent to which
the generation and transfer of evidence could support
decision making processes in health priority setting.
Little is currently known about the patterns of col-
laborations in HTA or economic evaluations of health
care interventions. This is the first study that explores
the geographic network of the Sub Saharan African
researchers in relation to HTA.
There were two main objectives of the study. First, to
consider the potential in the region to take advantage of the
results and methods of available HTA analysis. In order to
do so, we conducted a rapid evidence assessment of a rep-
resentative sample of academic articles that applied HTA
(specifically economic evaluations) in Sub-Saharan African
countries. Second, to analyse the main trends of the HTA
literature about Sub-Saharan Africa in terms of disease
focus, types of intervention evaluated, journal impact fac-
tors, and patterns of collaboration between authors within
and outside of Sub-Saharan Africa. These will provide an
indication of the level of advancement in health economic
evaluation, the topic areas in which the evidence is growing,
and elucidate the potential for transfer of evidence.
Method
Rapid evidence assessment
Rapid evidence assessments and systematic reviews are
both systematic processes of gathering and reviewing evi-
dence [27, 28]. The difference between the two lies in that
rapid evidence assessment is time-constrained and usually
aimed at capturing the key issues reflected in the evidence,
while a systematic literature review should exhaust all the
possible sources of information with less consideration
of the time and resources spent, and indeed whether
any additional information retrieved provides sufficient
value to outweigh the additional costs required in evi-
dence search and analysis.
There are limitations in rapid evidence assessment. First,
this method does not cover all available literature, and
could result in important evidence being missed from the
analysis. Similarly, rapid evidence assessment does not in-
clude grey literature. This means that economic evalua-
tions available for the decision makers but not published in
peer-reviewed journals are not reflected in the conclusions.
After considering the relative costs and benefits of both
methods, we selected rapid evidence assessment as the
more efficient and useful method for the current analysis.
Selection of articles
An electronic search for articles was conducted using
the NHS EED [6]. This comprehensive database includes
over 16,000 economic evaluations of health care inter-
ventions worldwide. Through an ongoing search of arti-
cles in MEDLINE, EMBASE, CINAHL, PsycINFO and
PubMed, NHS EED has collected all articles in which
the costs and outcomes of two or more interventions
are compared using cost-benefit, cost-utility, or cost-
effectiveness analyses. Given that the articles collected in
the NHS EED match our objectives, we based the rapid
evidence assessment on NHS EED. Note that the NHS
EED does not include systematic literature reviews.
In order to identify economic evaluations conducted
on Sub-Saharan Africa, our search terms were the names
of the 15 countries that are members of the Sub-Saharan
African Development Community (SADC): Angola,
Botswana, Democratic Republic of the Congo, Lesotho,
Madagascar, Malawi, Mauritius, Mozambique, Namibia,
Seychelles, South Africa, Swaziland, Tanzania, Zambia
and Zimbabwe. In addition, given HTA has seen consider-
able development in Ghana, Kenya, Nigeria, Ethiopia and
Uganda these five countries were also included. Since NHS
EED includes only economic evaluations, our search cri-
teria did not include any additional words, such as those
related to priority setting, HTA or economic evaluation.
The search was conducted with no language restriction,
but limited to documents included in the NHS EED data-
base before February 2015 and published between January
2004 and December 2014.
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In order to obtain a representative sample with a
manageable number of economic evaluations for every
country, we followed a three step selection process:
Step 1. The names of the selected countries were
searched one-by-one using the option “Any field” (i.e.
titles, abstracts and full texts).
Step 2. A subsample of articles was extracted separately
for each of the countries, such that a maximum of 10
articles per country was selected. Based on the number
of hits in Step 1, one of the following two actions was
carried out:
 For those countries in which the number of hits
was smaller than or equal to 10, all hits were
included in the subsample and the duplicated
articles were excluded.
Table 1 shows the results for the 9 countries in
which no more than 10 articles were found during
the search. No economic evaluations were identified
for Angola and Mauritius, thus these two countries
are not considered in the remaining analysis.
 For those countries with more than 10 hits, the
search was narrowed to the articles in which the
name of the country was mentioned in the title.
I. If the number of articles in which the name
of the country was mentioned in the title was
greater than 10 (South Africa, Tanzania, Zambia,
Ghana, Kenya, Nigeria and Uganda, see Table 1
column “(b) Name of the country in the title”),
10 articles were randomly selected, and
each assigned a number using the function
“sample()”of the program R 3.2.3 (The R Core
Team, 2016).
II. If the number of articles in which the name of
the country was mentioned in the title was 10
or fewer (Malawi, Mozambique, Zimbabwe and
Ethiopia, see Table 1 column “(b) Name of the
country in the title”) all the articles were selected.
III. Duplicated articles were excluded (see Table 1
column “(b) Duplicated articles”).
IV.With the objective of reaching 10 articles per
country, articles were randomly selected among
Table 1 Selection of articles
Country (a) Articles listed
in the NHS EED
database (# of hits)
(b) Name of
the country
in the title
(b) Duplicated
articles
(b) Number
of selected
articles
(c) Not
international
Affiliation
(c) Only
mentioned
in passing
Articles Included
in the analysis
Sub-Saharan African countries with fewer than 10 articles listed in the NHS EED database
Angola 0 0 0
Botswana 5 5 5
Congo 5 5 2 1 2
Lesotho 3 1 2 1 1
Madagascar 2 2 2
Mauritius 0 0 0
Namibia 2 1 1 1 0
Seychelles 2 2 2
Swaziland 3 1 2 1 1
Sub-Saharan African countries with more than 10 articles listed in the NHS EED database
Malawi 11 7 10 10
Mozambique 13 8 10 10
South Africa 105 53 10 10
Tanzania 34 20 10 10
Zambia 26 15 10 10
Zimbabwe 13 5 3 10 1 1 8
Ghana 13 11 10 10
Kenya 40 20 10 10
Nigeria 23 16 2 10 10
Ethiopia 11 8 10 1 1 8
Uganda 56 35 10 10
Total 367 119
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those not previously selected in I and/or II
(meaning those articles in which the name of the
country was not included in the title) (see Table 1
column “(b) Number of selected articles”).
Table 1 also shows the results for the 9 countries
in which more than 10 articles were found during
the search.
Step 3. After subsamples of articles were selected for
all countries, we excluded those articles where:
a) none of the first three authors’ institutional
affiliation was in Sub-Saharan Africa, or
b) the analysis was not focused on countries in
Sub-Saharan Africa, or
c) the country was mentioned only in passing in the
full text, meaning that the economic evaluation
pertained to a different country.
Table 1 shows for each of the three steps of the selection
process the number of selected articles per country. 119 arti-
cles were selected from which 13 articles pertained to more
than one Sub-Saharan African country. A full list of the ar-
ticles that include an author from more than one country
can be found in Appendix, Table 5. In the case of Namibia
and Swaziland, all the included articles consider more than
one Sub-Saharan African country. Figure 1 presents the
steps followed during the selection of the 119 articles.
For each of the 119 articles four categories of infor-
mation are extracted: 1) general information (i.e. title,
publication year, method, and journal of publication); 2)
geographic scope; 3) disease and type of intervention;
and 4) authors’ countries of affiliation. A detailed de-
scription of the information collected in each category
is presented in Appendix, Table 6.
Country of affiliation and network of the Sub-Saharan
African researchers
Next we explored the network of researchers with a
Sub-Saharan African. The research network was consid-
ered an indicator of the cooperation between research
workforces of the countries. Approximately one third of
articles (42/119) have a first author with an affiliation
from at least one Sub-Saharan African country (Appendix,
Table 7). Three of 42 appear twice as first authors, thus
the final subsample is equal to 39 different authors.
Co-authorship on scientific publications, a proxy for
collaboration [17], was used as the basis of the research
network analysis. We searched PubMed for all articles
published by all 39 authors between 1990 and 2014,
using the full name of the author (as appearing in the
selected article) as the search term. The 729 identified
publications are analysed hereafter as ‘network-articles’.
The first author of each network-article is considered
the main researcher of that study, and therefore also
considered the strongest collaborator. The name and
country of affiliation of the first author of each network-
article was extracted. In those cases in which the first
author of the network-article was the same as the author
of the NHS EED subsample, the country and name of
affiliation of the second author was used.
In order to examine for each first author the concentra-
tion of collaborations per country, we estimated the Her-
findahl Index (HI ). The Herfindahl Index is interpreted
here as the concentration of co-authors within any given
country, ranging 0 (having co-authors from a large num-
ber of countries) to 1.0 (having co-authors only in the
same country). It is estimated as HI ¼PNi¼1s2i where si is
the share of articles in which the co-authors’ affiliation
country is i as part of the total number of articles (N) pub-
lished by the author and registered in PubMed.
Fig. 1 Flow of studies in rapid evidence assessment
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In order to illustrate collaboration patterns and the
potential for information transfer between countries, we
plotted a connection map reflecting the number of paper
published by the 39 first authors, their countries of af-
filiation, and connections with researchers inside and
outside their countries.
Results
Disease focus of studies
Among the 119 sampled economic evaluations of health
interventions, most were related to four communicable
diseases: HIV/AIDS (42/119, 35.29 %), malaria (26/119,
21.85 %), tuberculosis (6/119, 5.04 %) and diarrhoea
(4/119, 3.36 %).
A small percentage (7/119, 6 %) of the articles were
not related to any particular disease. These can be classi-
fied into three groups, first those articles relating to the
health system organisation. For instance, the analysis
conducted by Curry, Byam [29] studied the impact of
large-scale interventions on primary care services for
women and children in low-income and rural areas. The
second group evaluated preventative interventions, but
without a clear link to any particular disease, such as the
work done by Hu, Grossman [30] in which three safe
abortion methods were compared with unsafe abortion
in terms of cost-effectiveness. A third group examined
methodological approaches. For instance, the investiga-
tion conducted Hansen and Chapman [31] who studied
the feasibility of conducting cost-effectiveness analyses
for a large number of health interventions in a develop-
ing country using a consistent methodology.
Regarding conditions other than communicable diseases,
the sample included 3.36 % (4/119) of studies on cancer
(breast and cervical cancers), 2.52 % (3/119) on acute
malnutrition and 1.68 % (2/119) on maternal mortality.
There was one example for the prevention of cardiovascu-
lar disease, and another for the use of antihypertensive
medications. The former analysed the cost-effectiveness
of singlerisk-factor management in comparison to man-
agement based on total cardiovascular risk factors in
Seychelles [32]. The latter evaluated the cost-effectiveness
of 4 classes of medications commonly used in Nigeria [33].
Types of intervention studied
Figure 2 classifies the sample of articles according to the
criteria used by the UK Medical Research Council
(MRC) [2]. This classification system breaks down the
health interventions into seven categories and 19 subcat-
egories (Appendix, Table 7). Figure 2 shows that the two
most common type of interventions analysed were thera-
peutic interventions and preventive interventions. Out of
the 27.73 % (33/119 articles) of observations classified as
therapeutic interventions, 15.97 % (19/119) were eco-
nomic evaluations of the introduction of a new drug.
Among preventive interventions, nutrition and chemopre-
vention comprised the highest proportion of observations
(16/119). Chemoprevention refers to the use of pharmaco-
logic or natural agents for the purpose of preventing
Fig. 2 Number of included articles by type of intervention. Source: Authors’ Elaboration
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disease or infection, and 11/16 articles analysed the effect
of HIV chemoprevention [34–43]. Moreover, more than
half the articles in the subcategories “nutrition and
chemoprevention” and “introduction of a new drug”
corresponded to treatments to prevent HIV transmission.
Finally there was a sizeable proportion of economic
evaluations (18/119, 15.13 %) analysing non-imaging
diagnostic tools.
Quality of publications
Journal impact factor is commonly considered as a proxy
for publication quality. The 119 selected articles were
published in 51 different journals; 8 of these journals did
not have a reported impact factor from International
Scientific Institute (ISI) [44]. 60 % of the selected articles
were published in 12 journals (see Table 2). PLOS ONE
(15.1 %), Cost Effectiveness and Resource Allocation
(9.2 %) and Malaria (8.4 %) comprised the highest share
of articles. The impact factors of the two first journals
did not exceed the weighted average impact factor of the
sample. The Cost Effectiveness and Resource Allocation
journal does not have a reported impact factor; however,
the value of the unofficial impact factor is 1.16 [45]
which is also below the average level.
Network analysis
Although all the 119 articles were about Sub-Saharan
Africa, the majority of the first authors (77/119, 64.7 %)
were affiliated to an institution outside Africa (Table 2).
This proportion was slightly smaller but still sizeable
among the second authors (62/118 authors, 52.5 %) and
third authors (54/112, 48.2 %).
Based on authorship, two countries are the leaders in
economic evaluations in Sub-Saharan Africa: the USA
and the UK. 43.3 % of the first three authors and 52.1 %
of the first authors were from one of these two countries
(Appendix, Table 7).
For the network analysis, we selected the 39 first
authors with an affiliation from Sub-Saharan Africa,
comprising 729 network-articles in total. The average
of network-articles per author was 18.69 (range 1 and
81) (Table 3). Out of the 20 countries included in the
original sample, 14 were represented by at least one of
the 39 first authors (Botswana, Congo, Ethiopia, Ghana,
Kenya, Lesotho, Madagascar, Malawi, Mozambique,
Nigeria, South Africa, Tanzania, Uganda, and Zambia).
The majority of the collaborations were with a re-
searcher from Europe (principally the UK), the USA
or within Africa. Regarding the connections inside
Africa, network-articles included those published with
co-authors from Nigeria (176/ 729), South Africa (95/
729) and Uganda (68/729). There were only a few
connections with Australia and Asia (Pakistan and
Saudi Arabia).
Table 3 shows the Herfindahl Index for each author.
Note that the authors with the highest number of arti-
cles did not have the lowest Herfindahl Indices, implying
that a well-established academic career does not neces-
sarily correspond with having research collabrators with
a large number of countries.
Figure 3 presents the connection map reflecting the
number of papers published and the countries of affili-
ation. The black points mark the countries to which the
39 first authors are affiliated (Table 3). Note that the
connections are analysed at country level but visually
represented on the map as connections between capital
cities.
The thickness of the red lines clearly shows that the
Sub-Saharan African authors are collaborating first with
authors of their own country. More than 65 % of the
network-articles with an author affiliated to an institu-
tion in Botswana, Kenya, Madagascar or Nigeria had the
first two authors affiliated to institutions in the same
country. For Uganda, the first two authors were affiliated
to institutions in the same country in 50 % of the
network-articles.
There was also a strong connection between Sub-
Saharan African researchers and researchers from the
USA and Europe, particularly the UK, which is observed
in the blue lines. Regarding the USA, the highest num-
ber of links was found with South Africa (30/124) and
Madagascar (16/22). In the case of the UK, the higher
number the network-articles was observed with South
Africa (24/124) and Nigeria (14/102). We also found a
sizeable proportion of the network-articles of Ghana and
Tanzania linked to the UK.
Additionally, the number and thickness of the green
lines indicates weak collaboration between Sub-Saharan
African researchers of different countries. Even among
authors of South Africa and Uganda, who were highly
active in the production of articles, there was little in-
dication of collaborations with other African countries.
However, the strongest connection between two Sub-
Saharan African countries occurred between South
Africa and Uganda, with seven network-articles.
Out of the 39 authors, 10 had two affiliations, of which
one was from a country outside Africa (USA, Belgium,
Norway, Spain or the UK). This could distort the
Table 2 Authors by Region of Affiliation (# Authors)
First author Second author Third author
Africa 31 50 54
Outside Africa 77 62 54
More than one affiliation
and at least one from Africa
11 6 4
Total 119 118 112
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Table 3 Number of network-articles and country of affiliation of the authors selected for the network analysis
Author Affiliation Country # of Network-
Articles
Co-authors’
affiliation Country
Herfindahl
Index
Co-authors’ second
affiliation country*
Akumu, Angela Oloo Kenya 2 Kenya 1.00
Bikilla, Asfaw Demissie Ethiopia/Norway 2 Norway 1.00
Ekwunife, Obinna Ikechukwu Nigeria 14 Nigeria 1.00
Kifle, Yibeltal A Ethiopia 1 Ethiopia 1.00
Kivuti-Bitok, Lucy W Kenya 3 Kenya 1.00
Ogu, Rosemary Nigeria 8 Nigeria 1.00
Opondo, Everisto Kenya 2 Kenya 1.00
Pemba, Dylo F Malawi 2 Malawi 1.00
Suleiman, Ismail Ayinla Nigeria 2 Nigeria 1.00
Tekeste, Asayehegn Ethiopia 1 Ethiopia 1.00
Leisegang, Rory South Africa 7 South Africa/USA 0.72
Uzochukwu, Benjamin Nigeria 66 Nigeria/UK 0.69
Ezenduka, Charles Nigeria 5 Netherlands/Nigeria 0.68
Mori, Amani T Tanzania/Norway 6 Norway/Tanzania 0.63 Norway
Samandari, Taraz Botswana/USA 26 Botswana /Botswana /South Africa /UK /USA 0.61 USA
Lemma, Hailemariam Ethiopia 7 Ethiopia /Sweden 0.56
Drain, Paul K. Madagascar 27 Canada/Madagascar/South Africa/Swaziland/USA 0.55 Cuba
Tumwesigye, Nazarius M Uganda 36 Australia/Ireland/Switzerland/UK/Uganda/USA 0.54 Sweden
Nonvignon, Justice Ghana 16 Congo/Ghana/Nigeria/USA 0.52
Badri, Motasim South Africa 53 Saudi Arabia/South Africa/UK/USA 0.52 Japan /UK
Schnippel, Kathryn South Africa 11 South Africa/USA 0.51 USA
Matangila, Junior R Congo/Belgium 2 Belgium/Congo 0.50
Onwujekwe, Obinna Nigeria 81 Nigeria/South Africa/Sudan/UK /USA 0.47
Zikusooka, Charlotte M South Africa 6 South Africa/Uganda/USA 0.44
Zurovac, Dejan Kenya 32 France/Kenya/UK/Uganda/USA/Zambia 0.44 UK
Osei-Kwakye, Kingsley Ghana 13 Gabon/Germany/Ghana/UK 0.44
Díez-Padrisa, Núria Mozambique/Spain 11 Mozambique/Spain/USA 0.39 Spain
Duffy, Kevin Uganda 11 Germany/UK/Uganda/USA 0.39
Ansah, Evelyn K. Ghana/UK 15 Ghana/Malawi/Netherlands/UK 0.38
Rosen, Sydney South Africa/USA 57 France/South Africa/USA/Zambia 0.38 USA
Nthumba, PM Kenya 19 Kenya/Spain/Switzerland/USA 0.38
Olusanya, Bolajoko O. Nigeria/UK 49 Benin/Germany/Nigeria/South Africa/UK/USA 0.36
Mbonye, Anthony K. Uganda 30 Canada/Denmark/UK/Uganda/USA 0.34 South Africa
Chanda, Pascalina Zambia 11 Kenya/South Africa/UK/USA/Zambia 0.28
Chhagana, Meera K South Africa 10 Norway/South Africa/Switzerland/USA 0.28
Albert, Heidi South Africa 12 Pakistan/South Africa/Switzerland/Uganda/USA 0.26
Armstrong Schellenberg,
Joanna RM
Tanzania/UK/
Switzerland
39 Brazil/Gambia/Spain/Switzerland/Switzerland/
Tanzania/UK/USA
0.22 Netherlands/
Spain/UK
Jouquet, Guillaume Lesotho 8 Belgium/Lesotho/South Africa/Swaziland/
Switzerland
0.20
Kolaczinski, Jan H Uganda/UK 26 Australia/Ethiopia/France/Kenya/Pakistan/South
Sudan/UK/Uganda
0.19 Switzerland/UK/
USA
Total 729 Average Herfindahl Index 0.59
*The second country of affiliation of a co-author is not considered in the estimation of the Herfindahl Index or in the network map
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findings since such authors would be expected to have
more co-authors from outside Africa. In order to ad-
dress this bias, Fig. 4 shows the connection map ex-
cluding the network-articles related to these 10 authors.
An important number of the connections between the
USA and South Africa, and between Uganda and the
UK, disappeared. Most important, the number of con-
nections between the African countries also decreased,
such as those with Ethiopia. Nevertheless, the pattern is
the same as in Fig. 3: the strength of collaborations was
clearly weaker between the African countries in com-
parison with the collaborations outside Africa.
Discussion
To our knowledge, this is the first published study aimed
at identifying patterns of collaboration between health
economic researchers in Sub-Saharan Africa, and also
the first study to apply bibliometric network analysis
techniques within the health economic evaluation litera-
ture. Our analysis suggests that collaboration between re-
searchers among Sub-Saharan African countries is weaker
than that between the Sub-Saharan African researchers
and their counterparts in USA and Europe, particularly
UK. This is similar to the results of Chuang, Chuang [8]
who applied a bibliometric analysis to public health re-
search in Africa, and found that the main collaborators
of East and South Africa were researchers from the
USA and the UK, while there was almost no connection
with countries in Asia. Similarly, Beattie, Renshaw [46]
showed that the highest number of collaborations between
African countries and countries outside the region related
to research in malaria were with UK and USA. Our find-
ings are consistent in suggesting that the assessment of
health technologies through the application of economic
evaluations in Africa appear to be influenced particularly
by two countries, USA and UK.
Our rapid evidence assessment suggests that among
Sub-Saharan African countries, South Africa has the
highest production of health economic evaluations as
well as the highest number of connections with other
African countries. This is in agreement with the analysis
by Wagstaff and Culyer [10] which found South Africa
to be the most productive among 25 countries in terms
of number of publications and citations related to health
economics. We found health economic evaluations relat-
ing to all Sub-Saharan African countries with the excep-
tion of Angola and Mauritius, however the quantity
varied considerably among the countries, from only two
registered studies (Madagascar, Namibia and Seychelles)
to more than 100 (South Africa). The apparent special
status of South Africa is consistent with that identified
in other studies of health research networks in Africa.
Ettarh [18] found that the strongest connections on car-
diovascular research occurred between South Africa and
Nigeria; and Onyancha [47] who analysed HIV/AIDS col-
laboration networks in Sub-Saharan Africa and concluded
Fig. 3 First author relationships according to affiliation country
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that while Uganda presented the largest number of author
networks, it was also the main research focus of the South
African research network, the other major HIV/AIDS
research network in the region.
Taken together, our findings suggest substantial vari-
ation in HTA capacity among Sub-Saharan African coun-
tries, that South Africa’s health system is better developed
to support evidence-based decisions in comparison with
the other countries, and South Africa would be well-
placed to consider as a centre for the creation of a regional
HTA network in Sub-Saharan Africa. Such a network
could facilitate the strengthening of capacity in countries
with fewer resources and less experience in the production
and use of health economic evaluations. The kinds of cap-
acity that might be lacking include data capacity, technical
capacity of researchers to conduct economic evaluations,
capacity of policymakers to commission, interpret and
use evidence, and the capacity of the health system to in-
centivise relevant research and knowledge translation
[48]. These various capacity gaps need to be addressed
accordingly in order to foster the production of relevant
and high quality economic evaluation that can sup-
port the policy makers’ decisions in health priority-
setting.
Our results show that most of the economic evalua-
tions conducted in Sub-Saharan Africa is biased towards
treatments of communicable diseases, in particular HIV
and malaria. This reflects the health priorities of the
Sub-Saharan African countries since communicable dis-
eases are among the five leading causes of disease bur-
den as well as having significant humanitarian and
economic impact in Africa [49]. Sub-Saharan Africa has
the highest prevalences of HIV worldwide [50], with
more than 19 million people living with HIV in the
countries listed in Table 4 (and more than 10 % of the
population in countries such as Botswana, Swaziland,
Lesotho and South Africa) [50]. Regarding malaria, the
WHO estimates that Africa accounted for 188 million
cases of malaria and 292,000 deaths in children aged
under 5 years in 2015 [51]. Moreover, since HIV and
malaria were central to the Millennium Development
Goals (MDGs), national and international funders have
devoted a large proportion of aid investments to pre-
venting and treating such diseases especially in Africa
[52, 53]. For instance, in Kenya, Ghana, Uganda, Nigeria,
Mozambique and Malawi less than 15 % of the health
expenditures related to HIV were from domestic public
funds [50]; and despite dramatic decreases in malaria
prevalence in countries such as Botswana, Namibia,
Ethiopia, Zambia, Zimbabwe, Swaziland and South Af-
rica over the past 15 years, healthcare expenditures des-
tined to malaria treatment and control still represents
substantial proportions of national health expenditures,
which are mostly covered by international funds [51].
Fig. 4 First author relationships according to affiliation country and excluding researchers with more than one affiliation
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Nonetheless, there were some studies of non-
communicable diseases in our sample and these may
increase in importance as the health priorities of Sub-
Saharan African countries are changing [33]. Additionally,
the results also indicate that the assessment of drugs and
non-imaging diagnostic tools are the two most common
types of technologies analysed.
This study had several limitations. First, from the ini-
tial sample of articles, only the first authors were consid-
ered in the network analysis. Most of the economic
publications recognize the participation of at least four
authors. In some of the studies included, the Sub-
Saharan African authors do not appear in the first three
names in the list of co-authors. To consider the research
network of all African co-authors could allow a more ro-
bust examination of the patterns potentially useful for
transferring knowledge. This is because these authors
have also acquired experience and skills that could be
useful for the development of HTA in Sub-Saharan
Africa. Moreover, in some publications the first author is
not the main researcher since some economics journals
list author names in alphabetical order. Second, the ana-
lysis did not explored the transferability of the evidence
itself, the extent to which the methods applied in one
African country can be applied to other country, or the
demand side of HTA evidence (policy decision makers).
Contextual factors could hinder transferability of and
positive spillover effects of generated research, and with-
out a strong political commitment production of HTA
evidence in unlikely to have a positive impact on the ef-
fectiveness and efficiency of health priority-setting [54].
Third, the use rapid evidence assessment meant that not
all the available literature was covered and this could have
resulted in a bias in the findings. However, this limitation
was partially compensated by the fact that NHS EED com-
prises an exhaustive search of articles in MEDLINE,
EMBASE, CINAHL, PsycINFO and PubMed. The NHS
EED database includes over 16,000 economic evaluations
of health care interventions worldwide reduced the likeli-
hood of missing key articles that could have an effect on
the results. Furthermore, we used random sampling to en-
sure that the included articles were representative of pub-
lications in Sub-Saharan Africa. Nevertheless, potentially
relevant grey literature such as country reports and
book chapters was not considered in this analysis; we
recommend for future investigation a systematic review
of the grey literature that, giving the lack of publicly
available evidence, considers measures to overcome the
difficulties in the collating economic evaluations in
Africa. Fourth, as a proxy for publication quality we
used the International Scientific Institute impact factor,
but this did not include all the journals in which the se-
lected articles are published. Therefore, future studies
should consider also other appropriate measures of
publication quality.
Conclusions
The need for setting priorities in health within limited
resources has stimulated the search for evidence-based
tools, such as HTA, to inform health policymakers dur-
ing the decision making process. Despite the increasing
attention of the scientific community on HTA, in Africa
the production of HTA analysis has been characterized
by lack of resources and human capital. Given that col-
laboration between researchers has been an important
element in the diffusion of knowledge in several fields of
study, it could be also a key factor to overcoming the
problems that generation and transferability of evidence
to support health priority setting in Africa.
Our study highlights important challenges facing the
transfer of HTA information between Sub-Saharan African
countries, as well as important opportunities. Collabor-
ation between Sub-Saharan African researchers is import-
ant in the generation and transfer of evidence to support
the decision making process for health priority setting.
However, collaboration between African institutions is cur-
rently weak and research appears to be heavily dependent
on collaboration with Europe and North America. There
Table 4 Journals and impact factors related to the articles in
the sample
Journal Articles Impact Factor*
Number % of the
sample
PLOS ONE 18 15.1 % 3.54
Cost Effectiveness and Resource
Allocation
11 9.2 % NA
Malaria Journal 10 8.4 % 3.49
Journal of Acquired Immune
Deficiency Syndromes
9 7.6 % 4.39
PLOS Medicine 4 3.4 % 14.0
Health Policy and Planning 4 3.4 % 3.00
Tropical Medicine and
International Health
4 3.4 % 2.30
AIDS 3 2.5 % 6.56
Bulletin of the World Health
Organization
3 2.5 % 5.11
Value in Health 3 2.5 % 2.89
American Journal of Tropical
Medicine and Hygiene
3 2.5 % 2.74
Weighted average impact factor for the full sample
(weighted by the number of articles)
4.959
Maximum impact factor for the
full sample
39.207 (Lancet)
Minimum impact factor for the
full sample
0.191 (Malawi
Medical Journal)
*SCI Journal Impact Factor: Measure that reflects the average number of
citations [44]
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are various possible explanations, of which we consider
two as the most plausible. First, the large amounts of
international funds invested in improving health in
Sub-Saharan Africa increases the interest of researchers in
development countries to conduct projects with a focus
on the region. Second, those African researchers that have
studied in American or European universities are in-
creasing the economic evaluation literature related to the
region in collaboration with their former colleagues and
supervisors. Our findings suggest that the mainstream of
academic thinking behind economic evaluations in Africa
is likely to respond more to the traditions in America and
Europe than those of Sub-Saharan Africa.
The relative strength of South Africa’s research network
means that it is well-placed to transfer international
evidence and best practices both from Europe and North
America, and to other countries in the Sub-Saharan
African region. In view of this, we recommend the
exploration and application of approaches to stimulate
networking among health economic researchers from
different African countries, and South Africa should be
central to any such efforts. Organizations and institutions
from high income countries interested in supporting
heath priority-setting in Sub-Saharan Africa could also
include promoting collaboration as part of their agendas.
Finally, follow-up studies should aim to capture com-
prehensively the research networks of all African authors
listed in the identified publications, and include an
exhaustive systematic review that includes published and
grey literature. The significant investment in terms of
human resources and time necessary to conduct such a
study requires the commitment of international organi-
zations and institutions from developed countries.
Additional files
Additional file 1: Contains the variables required for generating the
visual network maps. (CSV 43 kb)
Additional file 2: This is the R code for generating the visual network
maps. (R 1 kb)
Additional file 3: Database of included studies and characteristics,
network articles, authorship and collaborations. (XLSX 182 kb)
Appendix
Table 5 Articles that analysed more than one African country
Countries included in the study Title of the Article Year
Botswana/Kenya/South Africa/Tanzania Giving tranexamic acid to reduce surgical bleeding in sub-Saharan Africa: an
economic evaluation
2010
Botswana/Kenya/Tanzania/Uganda/Zambia/Zimbabwe. Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in
eight African countries
2004
Kenya/Mozambique/Tanzania/Uganda/Zimbabwe Health and economic impact of HPV 16/18 vaccination and cervical cancer
screening in Eastern Africa
2012
Kenya/Uganda Economics of switching to second-line antiretroviral therapy with Lopinavir/
ritonavir in Africa: estimates based on DART trial results and costs for Uganda
and Kenya
2011
Malawi/Mozambique Predicting trends in HIV-1 sexual transmission in sub-Saharan Africa through
the drug resource enhancement against AIDS and malnutrition model: anti
retroviral for reduction of population infectivity, incidence and prevalence at
the district level.
2012
Malawi/South Africa/Zimbabwe Cost-effective diagnostic checklists for meningitis in resource-limited settings 2013
Mozambique/Tanzania Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi)
in Mozambique and the United Republic of Tanzania
2009
Nigeria/Ghana Cost-effectiveness analysis of unsafe abortion and alternative first-trimester
pregnancy termination strategies in Nigeria and Ghana
2010
Nigeria/South Africa The potential cost and benefits of raltegravir in simplified second-line therapy
among HIV infected patients in Nigeria and South Africa
2013
South Africa/Malawi Expanding ART for treatment and prevention of HIV in South Africa: estimated
cost and cost-effectiveness 2011–2050
2012
Swaziland/Lesotho/Botswana/Malawi/Mozambique/Namibia/
South Africa/Tanzania/Uganda/Zambia/Zimbabwe/Kenya
Voluntary medical male circumcision: modelling the impact and cost of
expanding male circumcision for HIV prevention in eastern and southern Africa
2012
Swaziland/Tanzania/Uganda/Zambia Assessing effectiveness and cost-effectiveness of concurrency reduction for
HIV prevention
2011
Zimbabwe/Uganda Cost effectiveness analysis of clinically driven versus routine laboratory
monitoring of antiretroviral therapy in Uganda and Zimbabwe
2012
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Table 6 Information extracted from the selected articles
Category Name of the Variable Description
GENERALINFORMATION:
ARTICLE
Title Title of the article
Year (2004–2014) Publication Year
Method (cost-effectiveness = 1) In those cases in which the methodology applied can be classified as cost-effectiveness
analysis the value will be equal to 1. If that is not the case, the name of the methodology
applied should be included.
Journal Journal name
GEOGRAPHIC SCOPE Country Countries from the list of the selected countries that are analysed in the document.
Article focus is on Africa (YES/NO) Yes = The article analyses only African countries.
No = The analysis includes countries inside and outside Africa. In this case only those
articles in which at least one of the first three authors is from Africa are included.
DISEASE AND TYPE
OF INTERVENTION
Type of Intervention Based on the classification use by the MRC in its document Outputs, Outcomes and
Impact of MRC Research [55]:
• Diagnostic Tool – Imaging
• Diagnostic Tool - Non-Imaging
• Health and Social Care Services
• Management of Diseases and Conditions
• Preventative Intervention - Behavioural risk modification
• Preventative Intervention - Nutrition and Chemoprevention
• Preventative Intervention - Physical/Biological risk modification
• Products with applications outside of medicine
• Support Tool - For Fundamental Research
• Support Tool - For Medical Intervention
• Therapeutic Intervention - Cellular and gene therapies
• Therapeutic Intervention – Complementary
• Therapeutic Intervention – Drug
• Therapeutic Intervention - Medical Devices
• Therapeutic Intervention – Physical
• Therapeutic Intervention - Psychological/Behavioural
• Therapeutic Intervention – Radiotherapy
• Therapeutic Intervention – Surgery
• Therapeutic Intervention - Vaccines
Disease The analysis is related to the treatment, diagnostic or prevention of the
disease that is included in this column.
Main Conclusion Use the exact quotation as appeared in the abstract.
AUTHORS’ INFORMATION Authors Name of the first three authors.
Affiliation Country of the First,
Second and Third Authors
1) Only the first three authors.
2) In those cases in which the three authors have the same affiliation
country, only one country appears in this column.
Table 7 Country of Affiliation of the three first authors of the 119 selected articles
At least one African Affiliation* Affiliation from a Country outside Africa*
Country First author Second author Third author Country First author Second author Third author
Congo 0 1 2 Australia 1 1 0
Ethiopia 3 6 2 Belgium 1 0 0
Ghana 2 6 5 Canada 1 0 1
Kenya 5 4 4 Denmark 1 1 1
Lesotho 1 1 0 France 0 1 0
Madagascar 1 1 1 Germany 0 0 1
Malawi 1 3 2 Ireland 2 1 0
Mozambique 0 1 5 Italy 3 2 2
Nigeria 6 9 8 Japan 1 1 1
Seychelles 0 1 0 Myanmar 0 0 1
South Africa 7 8 8 Netherlands 5 3 1
Tanzania 0 0 1 Norway 2 1 1
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